Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

EACR 2012

7 - 10 Jul 2012
Molecular stratification of breast cancer: reaching the clinic
Prof Carlos Caldas - University of Cambridge, UK
Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )
25 Jul 2012
Circulating metastasis-initiating cells in breast cancer
Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany
Circulating metastasis-initiating cells in breast cancer ( Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany )
19 Jul 2012
The ceRNA Hypothesis and the non-coding revolution in cancer research and therap...
Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy ( Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA )
19 Jul 2012
Epithelial mesenchyme transition in cancer cells
Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore
Epithelial mesenchyme transition in cancer cells ( Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore )
18 Jul 2012
Australia Pancreatic Cancer Genome Initiative
Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Austra...
Australia Pancreatic Cancer Genome Initiative ( Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Australia )
18 Jul 2012
Underlying metabolic pathways in cancer
Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain
Underlying metabolic pathways in cancer ( Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain )
18 Jul 2012
Potential for micro-RNA based cancer treatments
Prof Carlo Croce – Ohio State University, Columbus, USA
Potential for micro-RNA based cancer treatments ( Prof Carlo Croce – Ohio State University, Columbus, USA )
18 Jul 2012
Understanding the mechanisms of breast cancer resistance
Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands
Understanding the mechanisms of breast cancer resistance ( Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jul 2012
Translational and tailored, but can we afford it?
Prof Gordon McVie - European Institute of Oncology and ecancer
Translational and tailored, but can we afford it? ( Prof Gordon McVie - European Institute of Oncology and ecancer )
17 Jul 2012
Translational and tailored, but can we afford it?
Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012
Cost efficiency of targeted therapy
Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy
Cost efficiency of targeted therapy ( Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy )
17 Jul 2012
Society and money - the cancer conundrum
Prof Richard Sullivan – Kings College, London, UK
Society and money - the cancer conundrum ( Prof Richard Sullivan – Kings College, London, UK )
17 Jul 2012
Translating cancer research to personalised treatment: Can it work?
Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Translating cancer research to personalised treatment: Can it work? ( Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
17 Jul 2012
The immuno side of melanoma
Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
16 Jul 2012
Constructing successful biomarker clinical trials
Dr Lisa McShane – National Cancer Institute, Bethesda, USA
Constructing successful biomarker clinical trials ( Dr Lisa McShane – National Cancer Institute, Bethesda, USA )
16 Jul 2012
Highlights of the 22nd EACR meeting and tackling glioblastoma
Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012
The changing field of drug development
Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
The changing field of drug development ( Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly )
16 Jul 2012
Epigenetics of cancer and changes in DNA modification in tumours
Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012